Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)

NCT00518245 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Low rate of patient recruitment. Cannot achieve sample size.

Conditions

Unstable Angina

Interventions

DRUG: enoxaparin

Sponsor

Canadian Heart Research Centre

Collaborators

[object Object]